ROME Therapeutics, Inc.
Biotechnology
ROME Therapeutics pioneers innovative treatments by exploring the dark genome, or the vast portion of human DNA overlooked by traditional drug discovery. Focusing on genomic repeats that activate in diseased cells, they aim to develop therapies for cancer, autoimmune disorders, and more. Their approach leverages advanced data science and insights into repeat biology to transform these unique genetic elements into groundbreaking treatments.
Founded: 2020
Rosana Kapeller, MD, PhD Co-founder, President and CEO |
Heike Keilhack, PhD Chief Scientific Officer |
Kyle Kuvalanka CFO and Chief Business Officer |